Menu
Back to User profile » Prof. Dr. Omar S Usmani
Papers published by Prof. Dr. Omar S Usmani:
Suboptimal Peak Inspiratory Flow and Critical Inhalation Errors are Associated with Higher COPD-Related Healthcare Costs
Leving MT, van Boven JFM, Bosnic-Anticevich SZ, van Cooten J, Correia de Sousa J, Cvetkovski B, Dekhuijzen R, Dijk L, García Pardo M, Gardev A, Gawlik R, van der Ham I, Hartgers-Gubbels ES, Janse Y, Lavorini F, Maricoto T, Meijer J, Metz B, Price DB, Roman-Rodríguez M, Schuttel K, Stoker N, Tsiligianni I, Usmani OS, Kocks JH
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:2401-2415
Published Date: 25 September 2022
Measuring Peak Inspiratory Flow in Patients with Chronic Obstructive Pulmonary Disease
Ohar JA, Ferguson GT, Mahler DA, Drummond MB, Dhand R, Pleasants RA, Anzueto A, Halpin DMG, Price DB, Drescher GS, Hoy HM, Haughney J, Hess MW, Usmani OS
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:79-92
Published Date: 6 January 2022
Small Airways Response to Bronchodilators in Adults with Asthma or COPD: A Systematic Review
Almeshari MA, Alobaidi NY, Sapey E, Usmani O, Stockley RA, Stockley JA
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3065-3082
Published Date: 11 November 2021
Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes
Price D, Jones R, Pfister P, Cao H, Carter V, Kemppinen A, Holzhauer B, Kaplan A, Clark A, Halpin DMG, Pinnock H, Chalmers JD, van Boven JF, Beeh KM, Kostikas K, Roche N, Usmani OA, Mastoridis P
Pragmatic and Observational Research 2021, 12:25-35
Published Date: 24 May 2021
Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence
Usmani OS, Roche N, Jenkins M, Stjepanovic N, Mack P, De Backer W
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:113-124
Published Date: 18 January 2021
Airway Deposition of Extrafine Inhaled Triple Therapy in Patients with COPD: A Model Approach Based on Functional Respiratory Imaging Computer Simulations
Usmani OS, Scichilone N, Mignot B, Belmans D, Van Holsbeke C, De Backer J, De Maria R, Cuoghi E, Topole E, Georges G
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2433-2440
Published Date: 7 October 2020
Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study [Corrigendum]
Bloom CI, Douglas I, Usmani OS, Quint JK
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:869-870
Published Date: 22 April 2020
Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
Bloom CI, Douglas I, Usmani OS, Quint JK
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:701-710
Published Date: 2 April 2020
Choosing the right inhaler for your asthma or COPD patient
Usmani OS
Therapeutics and Clinical Risk Management 2019, 15:461-472
Published Date: 14 March 2019
Functional respiratory imaging: heterogeneity of acute exacerbations of COPD
van Geffen WH, Hajian B, Vos W, De Backer J, Cahn A, Usmani OS, Van Holsbeke C, Pistolesi M, Kerstjens HAM, De Backer W
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1783-1792
Published Date: 30 May 2018
Changes in ventilation–perfusion during and after an COPD exacerbation: an assessment using fluid dynamic modeling
Hajian B, De Backer J, Vos W, van Geffen WH, De Winter P, Usmani O, Cahn A, Kerstjens HAM, Pistolesi M, De Backer W
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:833-842
Published Date: 6 March 2018
Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide
Singh D, Corradi M, Spinola M, Papi A, Usmani OS, Scuri M, Petruzzelli S, Vestbo J
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2917-2928
Published Date: 6 October 2017
Patients’ perspectives and preferences in the choice of inhalers: the case for Respimat® or HandiHaler®
Dekhuijzen PNR, Lavorini F, Usmani OS
Patient Preference and Adherence 2016, 10:1561-1572
Published Date: 18 August 2016